According to Abivax's latest financial reports the company has $0.28 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $28.86 M | -58.01% |
2021-12-31 | $68.74 M | 90.74% |
2020-12-31 | $36.04 M | 229.27% |
2019-12-31 | $10.94 M | -26.41% |
2018-12-31 | $14.87 M | -27.25% |
2017-12-31 | $20.44 M | -15.5% |
2016-12-31 | $24.19 M | -43.44% |
2015-12-31 | $42.78 M | 1103.01% |
2014-12-31 | $3.55 M | -22.16% |
2013-12-31 | $4.56 M |